Kerala Health Department has also asked the Drugs Controller to issue a notice to pharmacies not to sell pediatric drugs to children without a doctor's prescription
Deaths from ingesting contaminated cough syrups in India have occurred with distressing frequency for decades
NHRC issues notices to MP, Rajasthan and UP, asks states to probe children's deaths from alleged use of contaminated cough syrups
A batch of Coldrif cough syrup has been linked to multiple child deaths. Several states have banned its sale and authorities are probing the cases
DEG contamination in Coldrif cough syrup from Tamil Nadu has triggered state bans and a national probe amid fears of child deaths linked to toxic medicines
The Karnataka government has directed all enforcement officers to maintain strict vigil over certain cough syrups following reports of child deaths linked to their consumption in Madhya Pradesh and Rajasthan. In a circular dated October 5, the Food Safety and Drugs Administration (FSDA) said that in view of recent incidents where deaths have been reported in Madhya Pradesh following the consumption of Coldrif Syrup (Batch No. SR-13), manufactured by a Tamil Nadu-based pharma unit, the Tamil Nadu Drugs Control Department has prohibited the purchase, sale and consumption of the said batch in that state. Further, a few deaths of children have been reported in Rajasthan due to the consumption of Dextromethorphan Hydrobromide Syrup IP, manufactured by Kaysons Pharma, Jaipur, it stated. "All enforcement officers in the state of Karnataka are hereby instructed to keep a strict vigil on the above drugs/batch number and similar combinations from manufacturers. Any stockist, distributor, ...
The Telangana government has directed all District Medical and Health Officers (DM&HOs) to sensitise public on the 'alert' concerning the Coldrif cough syrup, which has been found "adulterated" with a toxic substance. In a communication to the DM&HOs, the Telangana government's Director of Public Health directed the officials to raise public awareness about the alert issued on September 4 by the state Drugs Control Administration to stop using Coldrif syrup of Batch No. SR-13, which has been allegedly found adulterated with Diethylene Glycol (DEG), a toxic substance. If people are in possession of the syrup, they should immediately report to the local drug control authority on its toll free number, the communication (dated October 5), shared with the media on Monday, said. The Director of Public Health also asked DM&HOs to strictly implement and disseminate the advisory issued by the Directorate General of Health Services (DGHS), Union Ministry of Health, regarding the ...
The Madhya Pradesh police have formed a special investigation team (SIT) to probe the death of 14 children in Chhindwara due to suspected renal failure, linked to the consumption of a toxic cough syrup, officials said. Dr Praveen Soni from Chhindwara has been arrested for alleged negligence in connection with the child deaths, while a case has been registered against the Coldrif cough syrup manufacturing company, the officials said on Sunday. The body of the last victim was exhumed on Sunday for a post-mortem. Chhindwara Additional Collector Dhirendra Singh said that ex gratia of Rs 4 lakh each, announced by Chief Minister Mohan Yadav, has been transferred to the bank accounts of the victims' families. Eight children are being treated in Nagpur -- four in a government hospital, one at the All India Institute of Medical Sciences (AIIMS) and three in private facilities, he said. Meanwhile, two children in MP's Betul district have died allegedly after taking Coldrif cough syrup, heal
The order also prohibits the import and export of the cough syrup in government and private institutions until further notice
Union Health Secretary Punya Salila Srivastava chaired a meeting with states after 11 children died in MP and Rajasthan, stressing strict GMP compliance and rational use of cough syrups in children
The Madhya Pradesh government has banned the sale of Coldrif cough syrup following the death of 14 children in Chhindwara due to suspected renal failure, with officials stating the drug samples were found to contain a highly toxic substance. The Central Drugs Standard Control Organisation (CDSCO) has also initiated risk-based inspections at the manufacturing units of 19 drugs, including cough syrups and antibiotics, across six states, the Union health ministry said on Saturday. A sample of the syrup, tested by the government drug analyst at the Drug Testing Laboratory in Chennai, was declared "Not of Standard Quality" by the Tamil Nadu Directorate of Drug Control, officials said here. The action by the Madhya Pradesh government came in the wake of the deaths of 14 children in Chhindwara district due to suspected kidney failure. Of these, 10 deaths were reported in Parasia subdivision since September 7, local officials said. Yogita (2), a resident of Parasia, died at a Nagpur hospit
The conference aims to discuss the rational use of cough syrups and ensure the quality of drugs following multiple child deaths linked to Coldrif cough syrup
Following the advisory issued by the Central Government, the state has appealed to doctors not to prescribe banned cough syrups for children
Senior Congress leader Kamal Nath on Saturday said the Madhya Pradesh government must give Rs 50 lakh each as financial assistance to families in Chhindwara that lost a child due to kidney failure after consuming adulterated cough syrup. The statement from Nath (78), a former chief minister and current MLA from Chhindwara, came after the Mohan Yadav government sanctioned Rs 4 lakh each as compensation to families of the 14 deceased. "So far, 10 children have died in Chhindwara after consuming the poisonous cough syrup. In this hour of grief, my condolences are with the bereaved families. But it must be remembered that this is not merely an accident but a man-made tragedy. I urge the Madhya Pradesh government to provide Rs 50 lakh each to the families of the deceased children," Nath said in a post on X. The families of some of the ailing children were paying from their own pockets for treatment, Nath said while urging the BJP government in the state to fully cover all medical ...
Contaminant found in Coldrif cough syrup; risk-based investigations started at manufacturing sites of around 19 drugs sampled across 6 states
The Tamil Nadu government has banned the sale of cough syrup 'Coldrif' and ordered its removal from the market following suspicions linking it to the death of 11 children in Madhya Pradesh and Rajasthan. With effect from October 1, the sale of the cough syrup manufactured by the city-based firm, has been prohibited across Tamil Nadu, an official of the Food Safety and Drug Administration Department said. Inspections were conducted at the pharmaceutical company's manufacturing facility in Sunguvarchathram in neighbouring Kancheepuram district during the last two days and samples have been collected, he said. The company, he said, supplies the medicines to Rajasthan, Madhya Pradesh, Puducherry. The samples would be sent to the government run laboratories to test for the presence of the chemical 'Diethylene Glycol', he told PTI. Taking cognisance of the infant deaths, the Union Health Ministry on Friday issued an advisory to all States and Union Territories, directing that cough and
Health ministry advisory urges rational use of cough syrups in children after 11 deaths in Madhya Pradesh and Rajasthan, though tests found no contamination in samples
A health scare has resurfaced in India after multiple cases of child deaths were linked to cough syrups in Rajasthan and Madhya Pradesh.
Drug authorities in Madhya Pradesh and Rajasthan are probing child deaths linked to cough syrup supplied to government hospitals, with testing of samples and quality concerns
The Rajasthan Health Department has clarified that the recent deaths of two children in Bharatpur and Sikar districts were not caused by cough syrup distributed under the state's free medicine scheme, according to an official statement. Public Health Director Ravi Prakash Sharma said inquiry reports confirmed that in both cases, the children were administered the syrup at home without a doctor's advice. As per protocol, Dextromethorphan (DXM) drug is not prescribed to children, Sharma said in the statement released on Thursday and added that in both incidents, the doctors had not prescribed the drug. Health Minister Gajendra Singh had earlier ordered a probe into the matter after reports of poor-quality cough syrup surfaced. Following the order, the Rajasthan Medical Services Corporation Limited (RMSCL) halted the supply and use of the drug, formed a three-member inquiry committee and sent some samples for testing at the state drug laboratory. However, in another case from Sikar,